methylene blue has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldberg, MS; Ju, X; Li, W; Liu, R; Mao, Z; Marvin, MA; Poteet, EC; Qian, H; She, H; Simpkins, JW; Tan, C; Wen, Y; Xie, L; Yan, LJ; Yang, SH | 1 |
| Gyr, K; Haensch, G; Kocher, R; Meran, A; Pfaltz, CR | 1 |
2 other study(ies) available for methylene blue and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection.
Topics: Animals; Cell Line; Electron Transport Chain Complex Proteins; Enzyme Inhibitors; Glycolysis; Male; Methylene Blue; Mitochondria; Neurons; Neuroprotective Agents; Oxygen Consumption; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Uncoupling Agents | 2011 |
[Unilateral vestibular paralysis of toxoplasmosis (author's transl)].
Topics: Adult; Audiometry; Cerebrospinal Fluid Proteins; Depression; Humans; Male; Methylene Blue; Movement Disorders; Neuritis; Nystagmus, Pathologic; Paralysis; Parkinson Disease, Secondary; Peripheral Nervous System Diseases; Personality Disorders; Serologic Tests; Toxoplasmosis; Vertigo; Vestibular Function Tests; Vestibular Nerve | 1974 |